IntelliDose and eClinicalWorks Partner for End-to-End Oncology Practice Management

Integrates leading chemotherapy management and EMR/PM systems.

Waltham, MA, and Westborough, MA, May 12, 2010—IntrinsiQ and eClinicalWorks® announce a partnership to integrate IntelliDose®, IntrinsiQ’s chemotherapy management solution, with the eClinicalWorks unified Electronic Medical Record (EMR) and Practice Management (PM) solution to give oncology practices a complete, best-of-breed health information system.

“There’s a reason IntelliDose is trusted by oncologists nationwide: It was created by oncologists for the specific demands of managing chemotherapy,” said Girish Kumar Navani, CEO and co-founder of eClinicalWorks. “The pairing of eClinicalWorks software and IntelliDose results in an end-to-end oncology management solution that meets the current and future needs of oncology practices of all sizes as well as hospitals and health systems.”

More than 40,000 providers and 120,000 healthcare professionals across all 50 states rely on eClinicalWorks. eClinicalWorks’ unified solutions allow extensive patient data to be shared within a network of physicians, while streamlining workflow, enhancing charge capture and eliminating the chase of paper charts.

While EMR systems create a clinical information hub for practices of all types, the specialty of oncology is particularly complex. Administering chemotherapy regimens requires calculating highly specific drug infusion instructions and dosing – that need to be altered in real-time based on a patient’s lab tests – and managing treatment over an extended period of time. This complexity demands a specialized clinical information management as well as charge capture system. Oncology patient data must integrate with other areas of a healthcare network, from surgery to lab to billing.

IntelliDose transforms the manual process of chemotherapy regimen calculations into electronically verified orders. It allows oncology practices to standardize cancer treatment pathways, and ensure the highest levels of patient safety and efficiency practice-wide. IntelliCharge™, the charge capture module of IntelliDose, automates chemotherapy coding and billing. Using detailed information from nurse charting steps, complete encounter information – including infusion time, type, and number of drugs – is sent directly to practice management or billing systems saving time, eliminating lost charges, and optimizing reimbursement. Both IntelliDose and IntelliCharge seamlessly interface with eClinicalWorks to integrate clinical and billing information into the patient record.

“After partnering for joint customer implementations, we’re pleased to formalize our relationship with eClinicalWorks,” said Jeff Forringer, president of IntrinsiQ. “With seamless data-sharing, physicians, nurses, practice administrators, and IT professionals spend less time on coordinating records – and more time on providing high-quality patient care.”

About eClinicalWorks
eClinicalWorks® is a privately held leader in the ambulatory clinical systems market. The company’s unified electronic medical record (EMR) and practice management (PM) solutions are proven for every market segment: large practice groups, including Massachusetts eHealth Collaborative (MAeHC), Electronic Health Records of Rhode Island (EHRRI) and the New York City Department of Health and Mental Hygiene, as well as medium, small and solo practices regardless of specialty. The company enjoys high profitability with a five-year compounded growth rate of more than 100 percent year-to-year. With an established customer base of more than 40,000 providers and 120,000 healthcare professionals across all 50 states, eClinicalWorks has been awarded multiple top industry honors including being named to the Inc. 5000 in 2009, 2008 and 2007. Based in Westborough, Mass., eClinicalWorks has additional offices in New York City, Pleasanton, Calif., and Alpharetta, Ga. More information on eClinicalWorks can be found at www.eclinicalworks.com or by calling 866-888-MYCW.

About IntrinsiQ
IntrinsiQ, LLC is the leading provider of medical oncology clinical information systems and the premier source of US oncology data and analysis. Each month, IntrinsiQ’s clinical software application, IntelliDose®, captures the treatment decisions and details from more than 600 oncologists, for nearly 20,000 unique patients, creating a database unrivaled in accuracy, detail and timeliness of information about the medical oncology care process. IntelliDose ensures patient safety though automation and standards designed to meet the needs of a specific practice, saving staff time, maximizing reimbursement and reducing operating costs. For more information, please visit www.intrinsiq.com.